These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7480201)

  • 21. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship.
    Abdel-Aziz M; Matsuda K; Otsuka M; Uyeda M; Okawara T; Suzuki K
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1669-72. PubMed ID: 15026047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition.
    Krishnan P; Bastow KF
    Anticancer Drug Des; 2000 Aug; 15(4):255-64. PubMed ID: 11200501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemical constituents from Corydalis humosa].
    Tao J; Zhang X; Ye W; Zhao S
    Zhong Yao Cai; 2005 Jul; 28(7):556-7. PubMed ID: 16252721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituted benzo[i]phenanthridines as mammalian topoisomerase-targeting agents.
    Makhey D; Li D; Zhao B; Sim SP; Li TK; Liu A; Liu LF; LaVoie EJ
    Bioorg Med Chem; 2003 Apr; 11(8):1809-20. PubMed ID: 12659767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topoisomerase-II-inhibitory principles from the stems of Spatholobus suberectus.
    Han AR; Park HJ; Chen D; Jang DS; Kim HJ; Lee SK; Seo EK
    Chem Biodivers; 2007 Jul; 4(7):1487-91. PubMed ID: 17638329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition by ellipticine derivatives of the reactions catalysed by the topoisomerases: preferential inhibition of topoisomerase II].
    Douc-Rasy S; Multon E; Kayser A; Riou G
    C R Seances Acad Sci III; 1983; 296(19):899-904. PubMed ID: 6311366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaloids from roots of Stephania rotunda and their cholinesterase inhibitory activity.
    Hung TM; Dang NH; Kim JC; Jang HS; Ryoo SW; Lee JH; Choi JS; Bae K; Min BS
    Planta Med; 2010 Oct; 76(15):1762-4. PubMed ID: 20391319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of DNA topoisomerases I and II and cytotoxicity by lignans from Saururus chinensis.
    Lee YK; Seo CS; Lee CS; Lee KS; Kang SJ; Jahng Y; Chang HW; Son JK
    Arch Pharm Res; 2009 Oct; 32(10):1409-15. PubMed ID: 19898804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517.
    Gupta M; Abdel-Megeed M; Hoki Y; Kohlhagen G; Paull K; Pommier Y
    Mol Pharmacol; 1995 Oct; 48(4):658-65. PubMed ID: 7476891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.
    Riou JF; Helissey P; Grondard L; Giorgi-Renault S
    Mol Pharmacol; 1991 Nov; 40(5):699-706. PubMed ID: 1658605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities.
    Riou JF; Fossé P; Nguyen CH; Larsen AK; Bissery MC; Grondard L; Saucier JM; Bisagni E; Lavelle F
    Cancer Res; 1993 Dec; 53(24):5987-93. PubMed ID: 8261412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of protoberberine alkaloids from the roots of Coptis japonica on catecholamine biosynthesis in PC12 cells.
    Lee MK; Kim HS
    Planta Med; 1996 Feb; 62(1):31-4. PubMed ID: 8720385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibitors of DNA topoisomerases].
    Andoh T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1526-35. PubMed ID: 9309151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid and simple determination of protoberberine alkaloids in Rhizoma Coptidis by 1H NMR and its application for quality control of commercial prescriptions.
    Li CY; Tsai SI; Damu AG; Wu TS
    J Pharm Biomed Anal; 2009 Jul; 49(5):1272-6. PubMed ID: 19345543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions.
    Li TK; Bathory E; LaVoie EJ; Srinivasan AR; Olson WK; Sauers RR; Liu LF; Pilch DS
    Biochemistry; 2000 Jun; 39(24):7107-16. PubMed ID: 10852708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA topoisomerase I-mediated formation of structurally modified DNA duplexes. Effects of metal ions and topoisomerase I inhibitors.
    Wang X; Henningfeld KA; Hecht SM
    Biochemistry; 1998 Feb; 37(8):2691-700. PubMed ID: 9485420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.
    Tanabe K; Ikegami Y; Ishida R; Andoh T
    Cancer Res; 1991 Sep; 51(18):4903-8. PubMed ID: 1654204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
    Hsiang YH; Jiang JB; Liu LF
    Mol Pharmacol; 1989 Sep; 36(3):371-6. PubMed ID: 2550774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.